BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

China

Mabwell's Biosimilar Denosumab solution approved by NMPA for osteoporosis treatment

Mabwell (688062.SH), an innovative biopharmaceutical company with the layout of whole industry chain, announced that the Denosumab solution for injection (...

April 04, 2023 | News

Lynk Pharmaceuticals Announces Positive Results for LNK01003 in Phase I Trial in Healthy Subjects

LNK01003 is an oral small molecule JAK inhibitor with intestine-restricted properties developed by the company for the treatment of ulcerative colitis and ...

April 04, 2023 | News

Genscript Biotech Reports 2022 Annual Results

Revenue of the Group for the year ended December 31, 2022 was approximately US$625.7 million, representing an increase of 27.7% as compare...

March 31, 2023 | Company results

Boao Forum for Asia Enters the Healthcare Sector

Boao, the seaside resort and convention destination on the South China Sea coast, has again caught the attention of the entire world. Boao Lecheng Internat...

March 31, 2023 | News

Ablaze Pharmaceuticals to Develop GPC3 Targeted Therapy for Liver Cancer in China

The proprietary GPC3 targeting peptide is being licensed from RayzeBio pursuant to an existing license agreement. Upon in-license of product candidates by ...

March 31, 2023 | News

ImmVira's MVR-C5252 for Malignant Glioma Approved for Clinical Trial in China

In July 2022, the Company entered into a cooperative agreement with China Resource Biopharma ("CRBio") to jointly develop MVR-C5252 in the Greate...

March 30, 2023 | Regulatory

Scivita Medical enters into Strategic Agreement with Boston Scientific in China

Under Scivita Medical's comprehensive product lineup of reusable endoscopes, single-use videoscopes and related systems and equipment, this cooperation fur...

March 30, 2023 | News

Kintor Pharma Completes Enrollment for KX-826 Phase III Trial for Male Androgenetic Alopecia in China

The Phase III clinical trial is a randomized, double-blind, placebo-controlled, multi-regional study designed to evaluate the efficacy and safety of 5mg (0...

March 29, 2023 | News

Antengene Doses First Patient with ATG-022 for Advanced Solid Tumors in Australia

Discovered and developed in-house by Antengene's R&D team, ATG-022 is an antibody-drug-conjugate (ADC) targeting the Tumor Associated Antig...

March 29, 2023 | News

Boan Biotech Announces 2022 Financial Results

Boan Biotech (6955.HK) today announced its 2022 financial results and recent business developments. 2022 business highlights Record high in revenue: In...

March 28, 2023 | News

Berry Genomics and Ajlan & Bros Holdings Form Joint Venture to Support 'Vision 2030'

The joint venture will focus on genetic testing in the field of reproductive health and carry out in-depth collaboration on a series of projects that lever...

March 28, 2023 | News

Everest Medicines receives full payment from Gilead for Trodelvy transaction, boosting cash reserves

"With the full upfront payment and other reimbursement from Gilead, we now have an even stronger balance sheet to advance development of products in our co...

March 28, 2023 | News

WuXi Biologics Reports Remarkable 2022 Annual Results

2022 Financial Highlights Revenue: The Group's revenue increased to RMB15,268.7 million with an increase of 48.4% y-o-y. The increase was...

March 23, 2023 | News

Jacobio Collaborates to Evaluate JAB-BX102 with KEYTRUDA® for Cancer Patients.

Jacobio Pharma (1167.HK) announced it has entered into a clinical collaboration with Merck & Co., Inc., Rahway, NJ, USA to evaluate the combinatio...

March 22, 2023 | News

Stay Connected